Figure 6.
In vivo efficacy in other tumor models, including CT26 and PDX model. (A) Real tumor volume changes of the CT26 tumor-bearing mice treated with various formulations. (B) Body weights of the CT26 tumor-bearing mice after treatment. (C) Real tumor volume changes of the PDX tumor-bearing mice treated with various formulations. (D) Body weights of the PDX tumor-bearing mice after treatment. The results are reported as mean ± S.E.M. *p < 0.05, **p < 0.01 (vs Taxol+GEM)).